We are testing a new treatment combining chemotherapy and a MEK inhibitor for patients with metastatic non-squamous non-small cell lung adenocarcinoma. The goal is to see if this approach is safe and effective for those with low PD-L1 levels.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-squamous non-small cell lung cancer (NSCLC) is a type of lung cancer that does not involve squamous cells. It is often diagnosed at an advanced stage and can be associated with symptoms like persistent cough, chest pain, and difficulty breathing.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.